{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T06:11:06Z","timestamp":1780639866621,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s40120-025-00780-4","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T10:57:07Z","timestamp":1750330627000},"page":"1657-1670","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of Early Antipsychotic Prescription Choice on Weight Gain in the First 5 Years of Psychotic Illness: a Retrospective Cohort Study"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9537-4050","authenticated-orcid":false,"given":"Adrian","family":"Heald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Tilston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Julian","family":"Warner-Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"Pillinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Deakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Longson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamiece","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin P.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Firth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"key":"780_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/0004867415625817","volume":"51","author":"AH Heald","year":"2017","unstructured":"Heald AH, Martin JL, Payton T, Khalid L, Anderson SG, Narayanan RP, De Hert M, Yung A, Livingston M. Changes in metabolic parameters in patients with severe mental illness over a 10-year period: a retrospective cohort study. Australian New Zealand J Psychiatr. 2017;51:75\u201382.","journal-title":"Australian New Zealand J Psychiatr"},{"key":"780_CR2","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1017\/S1461145712001277","volume":"16","author":"JP Zhang","year":"2013","unstructured":"Zhang JP, Gallego JA, Robinson DG, Malhotra AK, Kane JM, Correll CU. Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis. Int J Neuropsychopharmacol. 2013;16:1205\u201318.","journal-title":"Int J Neuropsychopharmacol"},{"key":"780_CR3","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","volume":"156","author":"DB Allison","year":"1999","unstructured":"Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, Weiden PJ. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatr. 1999;156:1686\u201396.","journal-title":"Am J Psychiatr"},{"key":"780_CR4","doi-asserted-by":"crossref","unstructured":"Cooper SJ, Reynolds GP; With expert co-authors (in alphabetical order):; Barnes T, England E, Haddad PM, Heald A, Holt R, Lingford-Hughes A, Osborn D, McGowan O, Patel MX, Paton C, Reid P, Shiers D, Smith J. BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment. J Psychopharmacol. 2016; 30: 717\u201348","DOI":"10.1177\/0269881116645254"},{"key":"780_CR5","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1001\/jamapsychiatry.2014.1314","volume":"71","author":"CU Correll","year":"2014","unstructured":"Correll CU, Robinson DG, Schooler NR, Brunette MF, Mueser KT, Rosenheck RA, et al. Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study. JAMA Psychiatr. 2014;71:1350\u201363.","journal-title":"JAMA Psychiatr"},{"key":"780_CR6","doi-asserted-by":"publisher","first-page":"14738","DOI":"10.1038\/s41598-017-15137-7","volume":"7","author":"RNS Harrison","year":"2017","unstructured":"Harrison RNS, Gaughran F, Murray RM, Lee SH, Cano JP, Dempster D, Curtis CJ, Dima D, Patel H, de Jong S, Breen G. Development of multivariable models to predict change in body mass index within a clinical trial population of psychotic individuals. Sci Rep. 2017;7:14738.","journal-title":"Sci Rep"},{"issue":"1","key":"780_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12991-023-00485-8","volume":"23","author":"A Heald","year":"2024","unstructured":"Heald A, Daly C, Warner-Levy JJ, Williams R, Meehan C, Livingston M, Pillinger T, Hussain L, Firth J. Weight change following diagnosis with psychosis: a retrospective cohort study in Greater Manchester, UK. Ann Gen Psychiatr. 2024;23(1):1.","journal-title":"Ann Gen Psychiatr"},{"key":"780_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/070674371405900203","volume":"59","author":"EJ Brandl","year":"2014","unstructured":"Brandl EJ, Kennedy JL, M\u00fcller DJ. Pharmacogenetics of antipsychotics. Can J Psychiatr. 2014;59:76\u201388.","journal-title":"Can J Psychiatr"},{"key":"780_CR9","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.4088\/JCP.08r04392","volume":"70","author":"V Simon","year":"2009","unstructured":"Simon V, van Winkel R, De Hert M. Are weight gain and metabolic side effects of atypical antipsychotics dose dependent? A literature review. J Clin Psychiatr. 2009;70:1041\u201350.","journal-title":"J Clin Psychiatr"},{"key":"780_CR10","unstructured":"https:\/\/gmwearebettertogether.com\/gm-care-record\/: Accessed 1 Aug 2024."},{"key":"780_CR11","unstructured":"https:\/\/www.who.int\/standards\/classifications\/classification-of-diseases: Accessed 14 May 2025."},{"key":"780_CR12","unstructured":"https:\/\/healthinnovationmanchester.com\/thegmcarerecord\/the-gm-care-record-for-secondary-uses-research: Accessed 21 Aug 2024."},{"issue":"Suppl 2","key":"780_CR13","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1136\/jech.49.Suppl_2.S30","volume":"49 Suppl 2","author":"SA Dolan","year":"1995","unstructured":"Dolan SA, Jarman B, Bajekal M, Davies PM, Hart D. Measuring disadvantage: changes in the underprivileged area, Townsend, and Carstairs scores 1981\u201391. J Epidemiol Community Health. 1995;49 Suppl 2(Suppl 2):S30\u20133","journal-title":"J Epidemiol Community Health"},{"issue":"2","key":"780_CR14","doi-asserted-by":"publisher","first-page":"e2579","DOI":"10.1002\/hup.2579","volume":"32","author":"A Heald","year":"2017","unstructured":"Heald A, Livingston M, Yung A, De Hert MA. Prescribing in schizophrenia and psychosis: Increasing polypharmacy over time. Hum Psychopharmacol. 2017;32(2):e2579.","journal-title":"Hum Psychopharmacol"},{"issue":"6","key":"780_CR15","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1093\/schbul\/sbaa060","volume":"46","author":"E Wagner","year":"2020","unstructured":"Wagner E, Kane JM, Correll CU, Howes O, Siskind D, Honer WG, Lee J, Falkai P, Schneider-Axmann T, Hasan A, TRRIP Working Group. Clozapine combination and augmentation strategies in patients with schizophrenia -recommendations from an international expert survey among the treatment response and resistance in psychosis (TRRIP) working group. Schizophr Bull. 2020;46(6):1459\u201370.","journal-title":"Schizophr Bull"},{"key":"780_CR16","doi-asserted-by":"publisher","DOI":"10.1177\/20451253211046765","author":"B Gupta","year":"2021","unstructured":"Gupta B, Chee KS, Neo LQ, Tang C, Hariram J, Tan GC, Verma S, Basu S, Appan DP, Ting CC, Abdin E, Lee J. Effect of aripiprazole as an adjunct to atypical antipsychotics on weight and metabolic profile: a 12-week open-label trial. Ther Adv Psychopharmacol. 2021. https:\/\/doi.org\/10.1177\/20451253211046765.","journal-title":"Ther Adv Psychopharmacol"},{"key":"780_CR17","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.2147\/NDT.S113099","volume":"13","author":"M Dayabandara","year":"2017","unstructured":"Dayabandara M, Hanwella R, Ratnatunga S, Seneviratne S, Suraweera C, de Silva VA. Antipsychotic-associated weight gain: management strategies and impact on treatment adherence. Neuropsychiatr Dis Treat. 2017;13:2231\u201341.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"3","key":"780_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/14740338.2020.1713091","volume":"19","author":"BB Barton","year":"2020","unstructured":"Barton BB, Segger F, Fischer K, Obermeier M, Musil R. Update on weight-gain caused by antipsychotics: a systematic review and meta-analysis. Expert Opin Drug Saf. 2020;19(3):295\u2013314.","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"780_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/acps.12468","volume":"133","author":"A Parabiaghi","year":"2016","unstructured":"Parabiaghi A, Tettamanti M, D\u2019Avanzo B, Barbato A, GiSAS study group. Metabolic syndrome and drug discontinuation in schizophrenia: a randomized trial comparing aripiprazole olanzapine and haloperidol. Acta Psychiatr Scand. 2016;133(1):63\u201375.","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"780_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4183\/aeb.2016.177","volume":"12","author":"VP Matei","year":"2016","unstructured":"Matei VP, Mihailescu A, Paraschiv G, Al-Bataineh R, Purnichi T. Weight gain and antipsychotics. Data from eufest study. Acta Endocrinol (Buchar). 2016;12(2):177\u201384.","journal-title":"Acta Endocrinol (Buchar)"},{"key":"780_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/14740338.2020.1713091","volume":"19","author":"BB Barton","year":"2020","unstructured":"Barton BB, Segger F, Fischer K, Obermeier M, Musil R. Update on weight-gain caused by antipsychotics: a systematic review and meta-analysis. Expert Opin Drug Saf. 2020;19:295\u2013331.","journal-title":"Expert Opin Drug Saf"},{"key":"780_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","volume":"7","author":"T Pillinger","year":"2020","unstructured":"Pillinger T, McCutcheon RA, Vano L, Mizuno Y, Arumuham A, Hindley G, Beck K, Natesan S, Efthimiou O, Cipriani A, Howes OD. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis. Lancet Psychiatr. 2020;7:64\u201377.","journal-title":"Lancet Psychiatr"},{"issue":"8","key":"780_CR23","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S2215-0366(19)30132-4","volume":"6","author":"J Firth","year":"2019","unstructured":"Firth J, Siddiqi N, Koyanagi A, Siskind D, Rosenbaum S, Galletly C, Allan S, Caneo C, Carney R, Carvalho AF, Chatterton ML, Correll CU, Curtis J, Gaughran F, Heald A, Hoare E, Jackson SE, Kisely S, Lovell K, Maj M, McGorry PD, Mihalopoulos C, Myles H, O\u2019Donoghue B, Pillinger T, Sarris J, Schuch FB, Shiers D, Smith L, Solmi M, Suetani S, Taylor J, Teasdale SB, Thornicroft G, Torous J, Usherwood T, Vancampfort D, Veronese N, Ward PB, Yung AR, Killackey E, Stubbs B. The lancet psychiatry commission: a blueprint for protecting physical health in people with mental illness. Lancet Psychiatr. 2019;6(8):675\u2013712.","journal-title":"Lancet Psychiatr"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-025-00780-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-025-00780-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-025-00780-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T20:47:17Z","timestamp":1757191637000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-025-00780-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["780"],"URL":"https:\/\/doi.org\/10.1007\/s40120-025-00780-4","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Adrian Heald, George Tilston, John Julian Warner-Levy, Loren Wilkins, Richard Williams, Toby Pillinger, William Deakin, Damien Longson, Lamiece Hassan, Caroline Dalton, Gavin P Reynolds and Joseph Firth have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"A favourable ethical opinion was provided by Greater Manchester Care Record Board (reference: IDCR-RQ-036). Deidentified data was used, as per the Health Research Authority\u2019s Governance arrangements nd in accordance with the Declaration of Helsinki. Human Ethics and Consent to Participate declarations were not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}